Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor

Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor

US Patent 5616492 · Granted Apr 1, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle diseas2014
Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degener2011
Preparation of compounds useful for the detection of hypoxia2008
Use of Bowman Birk inhibitor for the treatment of multiple sclerosis and other a2007
Preparation of compounds useful for the detection of hypoxia2007
Detection of hypoxia2005
Use of bowman birk inhibitor for the treatment of multiple sclerosis and other a2004
Methods for diagnosis and treatment of tumors in humans2001
Nitroaromatic compounds for the detection of hypoxia2001
Bowman-birk inhibitor compositions and methods for the treatment of genitourinar1999
Detection of hypoxia1998
Detection of hypoxia1998